“…In this scenario, reliable and predictive in vitro models of AC tissues in healthy and OA conditions play a critical role in advancing the understanding of the physiology, biology, and pathological progression of OA, and will contribute hugely to the development of novel regenerative treatments for OA ( Grenier et al, 2014 ; Johnson et al, 2016 ). A variety of proinflammatory cytokines are commonly used to induce the ECM degradation seen in human OA which involves factors i.e., interleukins (IL-1α, IL-1β, IL-6, IL-8, IL-9) and tumour necrosis factor (TNF-α) ( Gabriel et al, 2010 ; Novakofski et al, 2012 ; Sylvester et al, 2012 ). Amongst them IL-1β, TNF-α and IL-6 are the three cytokines mostly induced in OA pathogenesis and possess a synergic effect: (i) IL-1β, which was found to inhibit Coll II and proteoglycans (PGs) and stimulate the production of MMP1,3,13, (ii) IL-6 to activate NF-kB pathway and downregulate the enzymatic antioxidant defenses in chondrocytes with mitochondria; (iii) TNF-α, which can activate the NF-kB pathway, increase the expression of MMPs, inhibit anabolic molecules, and stimulate chondrocytes apoptosis ( Fan et al, 2007 ; Calich et al, 2010 ; Meliconi et al, 2013 ; Löfgren et al, 2018 ).…”